Grail Inc - Product Pipeline Analysis, 2020 Update



Grail Inc (Grail) is a healthcare company which conducts medical research for developing a blood screening test for early detection of cancer. The company utilizes population-scale clinical trials, data science, high-intensity sequencing and state of art of computer science to understand cancer biology and develop blood tests for early-stage cancer detection. Its area produces data and transforms it into clinically actionable insights to classify patients according to the presence, type, and severity of cancer. Grails clinical studies include Circulating cell-free genome atlas study (CCGA), SUMMIT study, and Strive study. The company has an operation with an additional office in Hong Kong. Grail is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Grail Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




Grail Inc Company Overview
Grail Inc Company Snapshot
Grail Inc Pipeline Products and Ongoing Clinical Trials Overview
Grail Inc Pipeline Analysis Overview
Grail Inc - Key Facts
Grail Inc - Major Products and Services
Grail Inc Pipeline Products by Development Stage
Grail Inc Ongoing Clinical Trials by Trial Status
Grail Inc Pipeline Products Overview
Blood-Based Test - Breast Cancer
Blood-Based Test - Breast Cancer Product Overview
Blood-Based Test - Breast Cancer Clinical Trial
Blood-Based Test - Lung Cancer
Blood-Based Test - Lung Cancer Product Overview
Blood-Based Test - Lung Cancer Clinical Trial
Multi-Cancer Early Detection Test
Multi-Cancer Early Detection Test Product Overview
Multi-Cancer Early Detection Test Clinical Trial
Grail Inc - Key Competitors
Grail Inc - Key Employees
Grail Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Grail Inc, Recent Developments
Feb 18, 2020: GRAIL initiates first interventional study using its Multi-Cancer Early Detection Test to guide clinical care
Jan 21, 2020: Blood-based test could help identify hard-to-detect gastrointestinal cancers
Dec 16, 2019: GRAIL appoints Gautam Kollu as Chief Commercial Officer
Oct 07, 2019: GRAIL appoints Matthew Young as Chief Operating Officer and Chief Financial Officer
Oct 07, 2019: GRAIL announces positive validation data for its Multi-Cancer Early Detection Test
Sep 30, 2019: GRAIL appoints Marissa Song as General Counsel and Corporate Secretary
Sep 28, 2019: GRAIL to present new data in late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2019 Congress
Aug 26, 2019: GRAIL appoints Rodger Currie as head of government affairs and alliance development
Jun 06, 2019: GRAIL announces appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with new appointments
Jun 03, 2019: Progress for Grails multi-cancer early detection blood test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Grail Inc Pipeline Products and Ongoing Clinical Trials Overview
Grail Inc Pipeline Products by Equipment Type
Grail Inc Pipeline Products by Indication
Grail Inc Ongoing Clinical Trials by Trial Status
Grail Inc, Key Facts
Grail Inc, Major Products and Services
Grail Inc Number of Pipeline Products by Development Stage
Grail Inc Pipeline Products Summary by Development Stage
Grail Inc Ongoing Clinical Trials by Trial Status
Grail Inc Ongoing Clinical Trials Summary
Blood-Based Test - Breast Cancer - Product Status
Blood-Based Test - Breast Cancer - Product Description
Blood-Based Test - Breast Cancer - Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection: The STRIVE Study
Blood-Based Test - Lung Cancer - Product Status
Blood-Based Test - Lung Cancer - Product Description
Blood-Based Test - Lung Cancer - The SUMMIT Study: Cancer Screening Study with or Without Low Dose Lung CT to Validate a Multi-cancer Early Detection Test
Multi-Cancer Early Detection Test - Product Status
Multi-Cancer Early Detection Test - Product Description
Multi-Cancer Early Detection Test - Assessment of the Implementation of an Investigational Multi-cancer Early Detection Test into Clinical Practice: The PATHFINDER Study
Multi-Cancer Early Detection Test - The Circulating Cell-free Genome Atlas Study
Grail Inc, Key Employees
Grail Inc, Subsidiaries
Glossary

List Of Figures


Grail Inc Pipeline Products by Equipment Type
Grail Inc Pipeline Products by Development Stage
Grail Inc Ongoing Clinical Trials by Trial Status

Grail Inc - Product Pipeline Analysis, 2020 Update

Grail Inc (Grail) is a healthcare company which conducts medical research for developing a blood screening test for early detection of cancer. The company utilizes population-scale clinical trials, data science,

USD 750 View Report

GRAIL Inc. - Tech Innovator Profile

GRAIL Inc. - Tech Innovator ProfileGRAIL Inc. is a healthcare company that develops blood test solutions that can help detect cancer in its early stages.ScopeThe report provides information and insights

USD 350 View Report

Binx Health Inc - Product Pipeline Analysis, 2021 Update

Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its

USD 750 View Report

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available